Patents Assigned to NEXVET AUSTRALIA LTD
  • TUMOUR NECROSIS FACTOR RECEPTOR FUSION PROTEINS AND METHODS OF USING THE SAME
    Publication number: 20180153987
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Application
    Filed: July 14, 2017
    Publication date: June 7, 2018
    Applicant: NEXVET AUSTRALIA LTD
    Inventors: Alexander DREW, David Gearing